ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,976.97
-1.13%
US Tech 100
21,079.20
-1.25%
Dow Jones
42,197.79
-1.79%
Brent Oil
73.815
0.00%
Bitcoin
105,707.98
0.23%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Capricor Therapeutics Inc (CAPR) Quote

Capricor Therapeutics Inc

Capricor Therapeutics Inc (CAPR)

Caprock Mining Corp
11.78
-2.16
(-15.49%)
Closed June 15 4:00PM
15 min delayed - Upgrade to Realtime
11.9999
0.2199
(1.87%)
After Hours: 7:59PM
15 min delayed - Upgrade to Realtime

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
11.9999
Bid
11.87
Ask
12.00
Volume
3,116,941
11.76 Day's Range 13.80
3.52 52 Week Range 23.40
Market Cap
548.489M
Previous Close
13.94
Open
13.55
Last Trade
500
@
11.9999
(formt)
Last Trade Time
Financial Volume
$ 39,415,355
VWAP
12.6455
Average Volume (3m)
2,229,631
Shares Outstanding
45,707,819
Dividend Yield
-
PE Ratio
-13.31
Earnings Per Share (EPS)
-0.89
Revenue
22.27M
Net Profit
-40.47M

About Capricor Therapeutics Inc

Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell t... Capricor Therapeutics, Inc. is a San Diego based biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy that is currently in late-stage clinical development for treating Duchenne muscular dystrophy (DMD). Capricor is also developing its exosome technology as a next-generation therapeutic platform. Capricor's proprietary StealthX¿ exosome platform has potential for a broad range of new therapeutic applications in the field of vaccinology as well as targeted oligonucleotide, protein and small molecule therapeutics to treat or prevent a variety of diseases. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.capricor.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Capricor Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CAPR. The last closing price for Capricor Therapeutics was $13.94. Over the last year, Capricor Therapeutics shares have traded in a share price range of $ 3.52 to $ 23.40.

Capricor Therapeutics currently has 45,707,819 shares outstanding. The market capitalization of Capricor Therapeutics is $637.17 million. Capricor Therapeutics has a price to earnings ratio (PE ratio) of -13.31.

Ask ADVFN Intelligence (AI)

Capricor Therapeutics (CAPR) Options Flow Summary

CAPR Options Flow

Overall Flow

Bearish

Net Premium

-1M

Calls / Puts

104.35%

Buys / Sells

100.00%

OTM / ITM

193.75%

Sweeps Ratio

6.38%

CAPR Latest News

More News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 14 2025
CAPR (-15.49%)

Form 8-K - Current report
Edgar (US Regulatory)
May 13 2025
CAPR (-15.49%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
April 09 2025
CAPR (-15.49%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
April 08 2025
CAPR (-15.49%)

Form 8-K - Current report
Edgar (US Regulatory)
April 08 2025
CAPR (-15.49%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.2551-9.4688796680513.2551511.7203480613.64010951CS
42.434925.45635128079.565159.0708215362311.56371634CS
12-2.1601-15.254943502814.16156.2722296319.89630396CS
26-2.2301-15.671820098414.2316.4656.27169008111.35655526CS
526.9499137.6217821785.0523.43.52180683212.67552791CS
1568.0499203.7949367093.9523.42.6872804211.30702918CS
2607.4999166.6644444444.523.42.567476059.03575125CS

CAPR - Frequently Asked Questions (FAQ)

What is the current Capricor Therapeutics share price?
The current share price of Capricor Therapeutics is $ 11.9999
How many Capricor Therapeutics shares are in issue?
Capricor Therapeutics has 45,707,819 shares in issue
What is the market cap of Capricor Therapeutics?
The market capitalisation of Capricor Therapeutics is USD 637.17M
What is the 1 year trading range for Capricor Therapeutics share price?
Capricor Therapeutics has traded in the range of $ 3.52 to $ 23.40 during the past year
What is the PE ratio of Capricor Therapeutics?
The price to earnings ratio of Capricor Therapeutics is -13.31
What is the cash to sales ratio of Capricor Therapeutics?
The cash to sales ratio of Capricor Therapeutics is 24.18
What is the reporting currency for Capricor Therapeutics?
Capricor Therapeutics reports financial results in USD
What is the latest annual turnover for Capricor Therapeutics?
The latest annual turnover of Capricor Therapeutics is USD 22.27M
What is the latest annual profit for Capricor Therapeutics?
The latest annual profit of Capricor Therapeutics is USD -40.47M
What is the registered address of Capricor Therapeutics?
The registered address for Capricor Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Capricor Therapeutics website address?
The website address for Capricor Therapeutics is www.capricor.com
Which industry sector does Capricor Therapeutics operate in?
Capricor Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RBNERobin Energy Ltd
$ 13.85
(313.43%)
101.81M
OPOceanPal Inc
$ 1.63
(125.45%)
80.28M
LGHLWLion Group Holding Ltd
$ 0.0052
(116.67%)
6.87M
NEONNeonode Inc
$ 16.83
(68.47%)
4.78M
ICONIcon Energy Corporation
$ 2.90
(62.01%)
59.04M
SBETSharpLink Gaming Inc
$ 9.2275
(-71.63%)
41.92M
AIHSSenmiao Technology Ltd
$ 0.381
(-63.01%)
16.8M
CHSNChanson International Holding
$ 0.22
(-60.00%)
15.15M
KWMK Wave Media Ltd
$ 2.91
(-50.43%)
2.59M
JZXNJiuzi Holdings Inc
$ 1.56
(-46.39%)
2.24M
HCTIHealthcare Triangle Inc
$ 0.0201
(-33.00%)
856.89M
GNLNGreenlane Holdings Inc
$ 0.0101
(-34.42%)
792.34M
CGBSCrown LNG Holdings Ltd
$ 0.1104
(31.43%)
788.42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.655
(3.81%)
246.13M
NVDANVIDIA Corporation
$ 141.97
(-2.09%)
180.81M

CAPR Discussion

View Posts
D-bol D-bol 1 week ago
I've been holding since 2021. What does everybody expect this to be this year?
👍️0
D-bol D-bol 2 weeks ago
Are you still here?
👍️0
GreedyAgorist GreedyAgorist 1 month ago
Anyone want to explain this complete pump eradication? It lasted 8 months... so... congrats on that, bulls.

So far it has been profitable to sell cash covered puts on this one when it has big drops, so I guess I should be happy for the opportunity, but I must say I did not expect to be looking at the 5's again. Only six weeks ago, I was selling a 25 call.
👍️0
koolmc koolmc 1 month ago
on watch again for another trade over reaction should see 10's again
👍️0
koolmc koolmc 2 months ago
trying for 14's now :)
👍️0
koolmc koolmc 2 months ago
13s :)
👍 1
koolmc koolmc 2 months ago
:)
👍️0
koolmc koolmc 2 months ago
if it breaks 12 and hold then uptrend confirms, although market not helping would be up more, but someone got a heads up here :)
👍️0
koolmc koolmc 2 months ago
yep finally sold some today after averaging down, will hold some into the forward event gl.
👍️0
ed3/6me ed3/6me 2 months ago
Life!
👍️0
ed3/6me ed3/6me 3 months ago
Bought back at 12.80 from 14.40. 
👍️0
koolmc koolmc 3 months ago
added 12 on dip, also got shares for short term trading gl
👍️0
koolmc koolmc 3 months ago
there it is below 12's again
👍️0
koolmc koolmc 3 months ago
up in down market today.
👍️0
koolmc koolmc 3 months ago
up in down market today.
👍️0
ed3/6me ed3/6me 3 months ago
Mid 12 is target again
👍️0
koolmc koolmc 3 months ago
Yep got plenty of time to accumulate cheapies before expected approval date wouldn't mind below 12s again to add.
👍️0
ed3/6me ed3/6me 3 months ago
waITING ON SIDELINES. AS THEY ARE NOT AGRESSIVE ENOUGH TO PUSH BUYING PRESSURE AS OF YET. THEY NEED SOMETHING TO STIMULATE THE NEED TO BE AGRESSIVE HERE.
👍️0
koolmc koolmc 3 months ago
yep same here will add to starter position i got last week for push into august then sell on news
👍️0
ed3/6me ed3/6me 3 months ago
Sold at 14.40 waiting now
👍️0
enthalpy enthalpy 3 months ago
It was strictly options and a great ER. Did you listen to it? I am going to load the boat in late April or early May probably another 20k. Wishing you and your family well. Enthalpy.
👍️0
enthalpy enthalpy 3 months ago
Hey Ed. Q4 2024 was a good time was is it not on CAPR. This is company is going to make it i think. ESpecially now that SRPT killed a kid. CAPR might become number 1 in DMD if they can get their drug approved. I sold a chunk at $18. Bought back at 11.80. Hope your doing man.
👍️0
ed3/6me ed3/6me 3 months ago
ANY RATIONAL TO THE BUMP YESTERDAY? THOUGHT THE TREND WAS SLIGHTLY LOWER TILL NEXT QUARTER AS THE COMPANY STILL HAS NO REAL APPROVAL YET
👍️0
ed3/6me ed3/6me 3 months ago
Agree about timing this. Lately it's a crapshoot anywhere. Market is unstable at best while war and tariffs/inflation are on front burner. Judges blocking the inevitable re evaluation of scope of government outreach clouds the pictures market cannot get a clear sense of direction. Think we still have 2-3 months of bounce here in investment land
👍️0
GreedyAgorist GreedyAgorist 3 months ago
So the bumpy ride is thanks to delaying the earnings report twice? (Or maybe the brokers were giving me bad info just to make me look foolish for the last two weeks.)

: - )

Now I wonder... does clearing this hurdle mean the monthly bottom was yesterday? Two days left for options expiration.
I will be picking up more shares at the end of the week. Just not sure how many. Price below or above 12.50 will determine that.
👍️0
ed3/6me ed3/6me 3 months ago
Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, will release its financial results for the fourth quarter and full year ended December 31, 2024, after the market close on Wednesday, March 19, 2025. Management will then host a webcast and conference call at 4:30 p.m. ET on March 19.
👍️0
ed3/6me ed3/6me 3 months ago
Nbd
👍️0
GreedyAgorist GreedyAgorist 3 months ago
Sorry, I could have sworn earnings were Wednesday last week, but they are this coming week, 3/12 after hours. Did one or two brokers lead me astray? Or was I looking at Rigetti or some other speculative play on my watchlist and got confused? Anyway…

Last week we did get some corporate stuff, some Form 4’s and an 8K, but no earnings yet. I thought the wild swings were in response to a quarterly report, and the worst of it was over, but no such luck.

Well, if it drops to 12, I will sell a 10 for April. Good luck to all.

And condolences to anyone who loses somebody over this stupid DST nonsense. When exactly does the making ourselves healthy again start? Certainly not this weekend.
👍️0
ed3/6me ed3/6me 3 months ago
can live with price short term. and hope they finally get going toward some kind of goal
👍 1
ed3/6me ed3/6me 3 months ago
Thanks. Will pay better attention next time 
👍️0
GreedyAgorist GreedyAgorist 3 months ago
You realize that earnings is today after hours. No doubt they will post a loss, as we are not at the point of having positive revenue yet, but just need to not disappoint.

Well, at least if you bought today, that is better than the recent top when it was 30% more expensive.

Still two and a half weeks until March contracts expire. A risk taker would position today, not wait until tomorrow, after the report. How brave am I feeling?
👍️0
ed3/6me ed3/6me 3 months ago
Jumped back in. Hope it helps me
👍️0
GreedyAgorist GreedyAgorist 4 months ago
Wow, I hardly ever perfectly time the bottom, but I sold a cash covered put today when it was red, and before I could second guess my play, it was green and up more than two bucks.

Any explanation for the 12% gain?

Oh, well, we were here ten days ago. Nothing to get excited about, right?
👍️0
Mr.Mister Mr.Mister 5 months ago
With BLA submission in late December, when would the FDA have to accept or reject their application by? Late February?
👍️0
Volcano Volcano 5 months ago
Breaking out now
Get ready for $70 upon FDA approval
💯 1 🔥 1
Volcano Volcano 5 months ago
Price target $70-$100 upon FDA approval in a few months
Multi millionaire soon to be
👍 1
XWAVXALMIMAN XWAVXALMIMAN 5 months ago
We got the news. We finished the submission and got $10 million. People are so impatient. I’ve waited 4 1/2 years. I can wait 6-9 months for approval. Families and patients should be pushing for a much quicker approval. 30-40 in 2025.
👍️0
D-bol D-bol 5 months ago
Maybe news tomorrow
👍️0
MomsSpaghetti MomsSpaghetti 6 months ago
My question to you CAPR folks who are likely more versed than I. Is after the submission is sent to FDA for approval (in your case Deramiocel (CAP-1002)) - How long does it take FDA to make a decision on average?

I am following another company MNMD that is in Phase 3 right now for LSD that got FDA Break Through Designation.
👍️0
GreedyAgorist GreedyAgorist 6 months ago
Guess I was wrong about the new 5. It is not 20 or 17.50. Not yet. Those were the pump prices. If the pump is over for now, we might hang out around 12.50 for a while, making puts at 12.50 and 10 interesting. Likewise calls at 15 might be worth a shot. Although my next play is targeting March 17.50. If it gets there early, that will inform my next move.
👍️0
XWAVXALMIMAN XWAVXALMIMAN 6 months ago
You’ll be sorry. Definitely an easy double from here within a year. I’ve held most shares for 4 1/2 years. Be patient. Linda sounded great - listened to interview last night after 12 days in Puerto Vallarta
👍️ 1
Laster Laster 6 months ago
Got out yesterday afternoon before that huge dump.
It looked like it wanted to drop below $16.
Crazy AH trading down to $11 and back to $16.
Concern about one of their investigators.
Either way, I am out and hope others can make a better trade than I did. Now moving my money to other more quality stocks. JMO.
👍️0
D-bol D-bol 6 months ago
What a day. Still not selling.
👍️0
PonkenPlonken PonkenPlonken 6 months ago
RFK is irrelevant to how CAPR moves.

Everything is in the price here... plus a lot of birds in the bush. Why anyone would hold this stock AFTER it all happened, no catalyst on the horizeon. Presentation roadmap ends at "today".... is clear indication they know nothing will happen for a good year or two. So it will need a breather - which I believe you see in the chart.

Bios run towards events - not because of them.
GL
👍️0
Laster Laster 6 months ago
Thank you. I have patience and can wait for mid 2025.
The problem is the biotech sector. It has gotten destroyed since Trump picked RFK Jr. as HHS secretary. Hopefully it will recover if RFK Jr. somehow doesn’t get the job.
Just hate the BS manipulation to drop stocks on no news. The stock market is a joke. Many Stocks now move on no news. I have seen stocks move from $1 to $10 on nothing. How is that possible or legal?
Just hope it doesn’t drop lower than $15. Then I might have to throw in the towel and move on.
👍️0
PonkenPlonken PonkenPlonken 6 months ago
This stock trades on a lot of hopes, dreams and "ifs".
Not unlikely that whatever they announce, it will be a sell on news event.
It believe it has to cool off until the PDUFA which is ca 1 year away.
When the roadmap a company gives in their presentation ends with "today"...... is usually not a good sign. That is speaking in terms of PPS. For the company, everything is well and funding wont be an issue.
👍️0
Laster Laster 6 months ago
Now down to $17.50. WOW. I can only guess people were expecting news on the BLA submission.
Maybe they are getting financing through the ATM and selling into the market.
Either way, this doesn't look good today.
👍️0
Laster Laster 6 months ago
This stock is ridiculous. I don't know if it is manipulation or MMs getting the stop losses?
Opened at $19.44 and then in 1 minute it went to $20.75 and then the next minute it is down to $18.92.
Clearly, someone continues to keep this below $20. When will they be done????
This is criminal IMO. I am holding because I think it makes a run to $30 once all this crap is over.
MACD histogram on the daily is going to turn positive today.
JMO.
👍️0
Laster Laster 6 months ago
The stock chart looks interesting. The MACD histogram is ready to turn positive.
The stock found support at the 25 day moving average.
PnF chart clearly shows double/triple top breakout past $21.
Nice flag forming. Needs volume to move past $20.
I think the stock will need BLA news to get the volume to move past $20.
I am looking for $30-$40 by mid 2025.

FYI. Conferences this week and next week.
Perfect time to release some updates.
👍 1
Laster Laster 7 months ago
Well yesterday sucked. Moved BACK to $20 again only to get dumped back down to $19.
Looks like it will need significant volume to move back above $20.
2 conferences in early to mid December might help.
Happy Thanksgiving.
👍️0

Your Recent History

NASDAQ
CAPR
Capricor Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads